Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia
The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US...
Brief Summary
Official Title: “Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia”
The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
- Study Primary Completion Date: April 2006
Intervention(s) in this Clinical Trial
- Drug: Fluvastatin
Outcome Measures for this Clinical Trial
Primary Measures
- Percent change from baseline in low density lipoprotein cholesterol after 12 weeks
Secondary Measures
- Percent change from baseline in total cholesterol after 12 weeks
- Percent change from baseline in high density lipoprotein cholesterol after 12 weeks
- Percent change from baseline in total triglycerides after 12 weeks
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Mixed dyslipidemia
- Primary hypercholesterolemia
Exclusion Criteria:
- Pregnant or lactating women
- Age > 18 years
- Other protocol-defined inclusion and exclusion criteria may apply.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 80 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Novartis Industry
Overall Clinical Trial Officials and Contacts
Novartis Study Director Novartis Pharmaceuticals
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00136799
Study ID Number: CXUO320B2302
ClinicalTrials.gov Identifier: NCT00136799
Health Authority: China: State Food and Drug Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00136799
